Tina C. Albershardt - Concepedia

Author

Tina C. Albershardt

University of Washington

Also Known As

David Hong, Tina Albershardt, Tina C Albershardt, Tina C. Albershardt, Tina Chang Albershardt

Publications

414

Citations

H-Index

Concepts

All Affiliations

University of Washington Merck & Co., Inc., Rahway, NJ, USA (United States)Fred Hutch Cancer Center Dartmouth College

About

Tina C. Albershardt is an author at University of Washington specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	190
2	Immunology	5	5	190
3	Cell Biology	2	2	122
4	Engineering	1	1	17
5	Pathology	1	1	18

Tina C. Albershardt

Publications

377

Citations

H-Index

Page 1

	Year	Citations
Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA Tina C. Albershardt, Bethany L. Salerni, Ryan S. Soderquist, Journal of Biological Chemistry Reductive StressHematological MalignancyProtein FunctionSignal TransductionBh3 Mimetics	2011	104
Regulatory B cells preferentially accumulate in tumor-draining lymph nodes and promote tumor growth Sheila Ganti, Tina C. Albershardt, Brian M. Iritani, Scientific Reports	2015	75
Vinblastine Induces Acute, Cell Cycle Phase–Independent Apoptosis in Some Leukemias and Lymphomas and Can Induce Acute Apoptosis in Others when Mcl-1 Is Suppressed Bethany L. Salerni, Darcy Bates, Tina C. Albershardt, Molecular Cancer Therapeutics	2010	60
LV305, a dendritic cell-targeting integration-deficient ZVex TM -based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response Tina C. Albershardt, D. J. Campbell, Andrea Parsons, Molecular Therapy — Oncolytics	2016	35
Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors Tina C. Albershardt, Jardin Leleux, Andrea Parsons, npj Vaccines T-regulatory CellImmunologyImmunoeditingImmune Cell TherapyImmunotherapy	2020	30
Therapeutic efficacy of PD1/PDL1 blockade in B16 melanoma is greatly enhanced by immunization with dendritic cell-targeting lentiviral vector and protein vaccine Tina C. Albershardt, Andrea Parsons, Rebecca Susan Reeves, Vaccine Tumor ImmunologyProtein VaccineMedicineMelanomaImmunology	2020	21
Distinct mechanisms of B and T lymphocyte accumulation generate tumor-draining lymph node hypertrophy Lauren M Habenicht, Tina C. Albershardt, Brian M. Iritani, OncoImmunology Distinct MechanismsLymphocyte DevelopmentT-regulatory CellImmunologyPathology	2016	18
Evaluation of reference genes for quantitative PCR analysis of mouse lymphocytes Tina C. Albershardt, Brian M. Iritani, Alanna Ruddell Journal of Immunological Methods EngineeringLymphocyte DevelopmentMedicineGeneticsMouse Lymphocytes	2012	17
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Casey R. Ager, Matthew J. Reilley, Courtney Nicholas, Journal for ImmunoTherapy of Cancer	2016	17

Page 1